Wyss Institute at Harvard University

Researchers at the Wyss Institute and collaborating institutions moved the needle on using extracellular vesicles (EVs) as a rich source of biomarkers for Parkinson’s Disease and other disorders of the brain and other organs. By advancing their “liquid biopsy” platform, they developed the ability to, for the first time, exactly answer the simple but challenging question of what portion of a given protein present in blood plasma is actually inside of EVs relative to outside. Read more in Inside Precision Medicine. #BrainHealth #ParkinsonsDisease #Diagnostics https://lnkd.in/eSppt8V6

Gozde Basara has never shied away from learning something new. From starting a Ph.D. in 3D Bioprinting as a mechanical engineer with no advanced knowledge of biology to taking on new artistic endeavors like crocheting, watercolor painting, and singing, she doesn’t back down from a challenge. The latest one? Developing a technology to help cancer survivors safely feel whole again following mastectomies. As part of the ReConstruct team, she’s refining a way to make vascularized tissue from a patient’s cells for safer reconstruction surgeries. Learn more about Gozde and her work in this month’s Humans of the Wyss. #HOWyss?#WomensHealth #CancerSolutions #3DPrinting #Bioprinting https://lnkd.in/eawgTP6P

Lumineers are members of the Wyss community who have left academia and entered industry to translate their technologies into products that can transform healthcare and sustainability. To celebrate Entrepreneur's Day, check out this roundup of their best advice for life sciences entrepreneurs. #Entrepreneurship #Advice #EntrepreneursDay https://lnkd.in/eKZwbRuZ

?? Happy Birthday to our favorite Scorpio, Natalie Artzi! ?20-ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, and interests, as well as their research. This first round follows Natalie Artzi, a new addition to the Wyss Institute’s core faculty. #Wyss20ishQs #UniquelyWyss #Faculty Massachusetts Institute of Technology Brigham and Women's Hospital Harvard University

The HarborSite platform, developed at the Wyss, enables safe and durable gene and cell therapies for diseases of liver, blood, lung, skin, and other tissues. HarborSite is able to overcome key limitations of existing gene therapies by combining two proprietary genome editing technologies –?genomic safe harbors and highly effective recombinase enzymes. https://lnkd.in/eRGFaQGN

Researchers at the Wyss Institute and Harvard SEAS developed a new type of catalytic material that dramatically lowers the cost of cleaning air. This new material, inspired by the honeycomb-like nanostructure of butterfly wings, is applicable to many industries and settings, including high-temperature chemistry, home and commercial HVAC, transportation, manufacturing, pharma, and agriculture. This technology is available for licensing. #Sustainability #AirPollution #CleanAir https://lnkd.in/gEuyUxmB

♀? ?? The Wyss Institute is making bold strides in women’s health, where disparities have long gone unaddressed. ?? Through data-driven innovations and cross-disciplinary partnerships, the Wyss aims to close the gender gap in healthcare by championing personalized diagnostics, tailored treatments, and technologies for conditions that disproportionately affect women. ??? At our recent Women’s Health Symposium, industry leaders, investors, researchers, and advocates gathered to spark systemic change, underscoring the need for substantial investment and collaboration to address critical issues in women’s health. With 30+ active projects, the Wyss is charting a transformative path toward health equity, and inviting others to join this crucial movement. #WyssWomensHealth #FemTech #WomensHealth https://lnkd.in/eFpniCNE

Are you interested in contributing to the development of a comprehensive effort focusing on diagnostics for human and planetary health? We are seeking a Principal Engineer - Diagnostics. In this role, you will lead multiple projects, focusing on developing analytical assays, sensors and diagnostic devices. You will be exposed to many different technology platforms and evaluate them toward their potential to drive scientific understanding, decision-making, and solutions in healthcare and environment, with the unique opportunity to fuel your passion by leading these efforts over time at the Institute or by co-founding a Wyss start-up. Apply to join our community today! #Hiring #OpenPosition #EngineeringJob #BioengineeringJob https://lnkd.in/egHkj-Zx

An international team of researchers, including Wyss scientists, found a new strain of algae, nicknamed "Chonkus," that is especially adept at growing rapidly in the presence of CO2. Chonkus could help sequester carbon and combat climate change. Read more in Popular Mechanics. #Sustainability #ClimateChange #ClimateSolutions https://lnkd.in/e2ZdF-GU

We’re developing DNA Origami nanodelivery, which is transforming the nanoparticle industry. Developed at the Dana-Farber Cancer Institute and the Wyss, this innovative approach overcomes the challenges of other nanoparticles, offering stability, high drug loading capacity, nano-scale control of cargo spacing, and more – making it a highly customizable solution for delivering critical medicines. Learn more about the DoriVac technology: https://lnkd.in/eXJ7PQ_X Yang (Claire) Zeng Jessica Baker Flechtner #CancerVaccine #DNA #Nanotechnology